Clinical Trial Update: AXER-204 in Participants With Chronic Spinal Cord Injury [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial in Chronic Spinal Cord Injury has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• AXER-204

Snippet

Sponsor: ReNetX Bio, Inc. | Conditions: Chronic Spinal Cord Injury | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-08-22